Member Info for icepick

In respect of GDR the majority on here are bereft of any useful knowledge to inform or share.

empty vessels make the loudest sound!

More jam tomorrow

Will you give it a rest

This is the GDR BB

Will you give it a rest

This is the GDR BB

And I am more than happy holding 2 x 'Gold Standard' products

GLA

We're on the move now

GLA

thats on a single shift schedule.

do you not think theres a possibility they would double shift?

Blue

I would also add that 3 months ago NCYT only had circa 1/3 of sales to date sales and circa twice the sp to date.
ie circa £50m vs SP £5

what MC does that equate to?

Bottom called yesterday @ 64

I expect more upward movement from here

I'm calling the bottom.

20% off placing price

80 - 16 = 64p

GLA

Contact Us
A 296/1 3rd Floor Okhla Phase I Industrial Area, New Delhi 110020
?+911149074623

DIVOC Health is formed to reverse the COVID19 Pandemic. Using Innovative Products and approaches, DIVOC aims to address needs of the Indian healthcare market. DIVOC Health is a a new enterprise bringing innovative healthcare products into the Indian Market established by Dr Kanav Kahol, a former professor from Arizona State University and Mayo Clinic USA and a renowned healthcare innovator in partnership with Lion’s Head Global Partners. To address the Immediate need for India to have access to high quality COVID19 Tests DIVOC is bringing GeneDrive RT PCR COVID19 Tests to India. The availability of accurate, high quality tests is critical part of India’s defence against Covid19. We identified the Genedrive test as being particularly well suited to the Indian market due to its thermostability, reduced processing steps and high quality manufacture. DIVOC has applied for regulatory clearance in India. The Indian regulatory process has recently been amended and now requires successful performance evaluation by the Indian Council of Medical Research, which DIVOC is pursuing. The Company is optimistic that India registration could be obtained. DIVOC is also working on healthcare delivery models that will enable quality healthcare to be delivered through technology.

DIVOC has partnered with GeneDrive to bring their Genedrive® 96 SARS-CoV-2 Kit to the Indian market.
This kit has unique propositions that make it suitable for the Indian environment.

I think some are being overly optimistic in results being 1st week July.

Simple loose calculation would be :-
Date last patient recruited +
14 days treatment +
28 day follow - up +
2 weeks to unblind, analyse, and publish results
= end of July

Good news without a doubt, however may take some time to achieve.

The Home trail is targeted at the 'shielded' population
Being 'shielded' is by definition supposed to minimise the exposure and risk of catching the virus at all.

How many 'shielded' people are there living in the 40 mile radius of Southampton and how many 'shielded' people will actually end up with the virus?

Or what percentage of the UK 'shielded' population are likely to catch it ?

Thoughts anyone?

I bought in just after the 14p peak paying 12p back in November last year.
At that time I had really high hopes for the company and when it started to drop I believed I had no other option than to buy some more (rude not too!).

Surprised and somewhat disappointed that it continued to fall but bought more and got my average down to 9p and yet again more lower still got my average down to 7.5p and when it hit 4 yep I bought more and ended up with an average of 5.5p.

When it dropped below 4p I started to get worried as I now had all my eggs in one basket and was definitely overweight. I still held belief that this would come good only now I was taking the risk a little too far.

so I set myself a strategy that I felt comfortable with (if I could achieve it)

I decide that once the sp had broken break-even I would sell half my holding. This I managed to do and fortunately @circa 6p

Still with the belief things will come good and buoyed by the rising sp which went up even more, I decide to let the other 50% ride proviso the sp stayed above my B/E. And if the sp drop to B/E or below I would sell half.

Today I did just that. I now only hold my original quantity but at an average of 5.5p instead of 12p.

I still believe it will come good and still hoping to get a result.

I now have a more diverse portfolio and I now sleep much better at night !!

It has been flagged and discussed many times before.

In the other place, Nobby has had confirmation & explanation from Richard that the 400 represents more than the initial trial as 'place holders' should the trial need or chose to be extended, as was the case with the home trials being added.

With the initial hospital trial already well underway, it would be impossible to include the results of any extension within the voiced 'end of June' deadline, therefore the possibility of up to 400 patients the deadline has been set with some leeway to cover all eventualities.

All things being equal, I guess we should hear news on Home Trials commencement pretty soon.
And I still expect results of hospital trials by end of June.

Isn't Market Capital derived from share price!

Very disappointing.
Something doesn't quite feel right
I'm out with a £700 loss.

GLA

And d66 has started a 2nd account (dougiescotland) just to give his d66 drivel a 'recommended'

D66

spouting the usual DRIVEL

Try doing some research